长读长测序技术在肿瘤领域中的应用:进展与挑战
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Application of long-read sequencing in oncology: progress and challenges
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    相较于目前普遍应用的二代测序(NGS)技术,长读长测序(LRS)技术是一种能够连续读取数百万个碱基对的测序技术。本文回顾了单分子实时测序技术、牛津纳米孔测序技术和新型单分子LRS技术在肿瘤领域的研究应用。LRS技术能够更精确地检测肿瘤基因组变异,包括结构变异、拷贝数变化、基因融合等。除基因组变异检测外,LRS技术还为描绘转录组图谱、表观遗传修饰图谱提供了有效手段。LRS技术可以有效弥补NGS技术的部分技术瓶颈,深入揭示生物大分子在健康和疾病状态下的复杂性状,为更好地理解肿瘤的发生与发展机制、制定治疗策略和开发药物提供新的理论基础。此外,本文还展望了LRS技术在肿瘤领域临床应用中的潜在价值。

    Abstract:

    Compared to the commonly used second-generation sequencing (NGS), long-read sequencing (LRS) is capable of continuously reading millions of base pairs. This article reviews the recent progress in the applications of single-molecule real-time sequencing technologies, Oxford nanopore sequencing technologies and novel single-molecule LRS technologies. LRS technologies facilitate the detection of genomic variations, including structural variations, copy number changes, gene fusions, etc. Moreover, LRS technologies provide an effective tool for profiling transcriptome and epigenetic modification. LRS can also solve part of the technical bottleneck of the NGS and help to reveal the complexity of biological macromolecule in health and disease conditions, which may provide a new theoretical basis for better understanding the mechanisms of carcinogenesis and malignant progression, subsequently leading to development of novel therapeutic strategies and drugs. Besides, this review outlines the potential advantages of the application of LRS in clinical practice of oncology.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-12-05
  • 最后修改日期:2023-02-15
  • 录用日期:
  • 在线发布日期: 2023-04-26
  • 出版日期: 2023-04-20
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭